Pull to refresh
Logo
What Changed
Following Why Sign Up
ARPA-H launches SPECTRA, an AI-driven initiative to transform autism diagnosis

ARPA-H launches SPECTRA, an AI-driven initiative to transform autism diagnosis

New Capabilities

First SPECTRA deadline closes with enabling-technologies track shut to new submissions; three tracks still ahead

October 21st, 2026: TA4 solution summaries close

Overview

Updated Oct 22

The first SPECTRA deadline has passed. Solution summaries for Technical Area 4, the enabling-technologies track, closed October 21 at 3 p.m. ET, three days later than the original October 18 date, and ARPA-H's program page now lists the track as closed to new submissions.

Next are the analysis and modeling tracks, which open to submissions November 18 and close December 2. Precision intervention summaries are due January 19, 2027. ARPA-H launched SPECTRA on September 17 to pair biological data and AI models with the goal of mapping each person's autism trajectory; the TA4 track asks for tools that measure real-world function as a byproduct of ordinary use.

Why it matters

SPECTRA could shift autism assessment from scarce specialist observation to data-driven tools usable in homes, schools, and clinics.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

4
SPECTRA technical areas
Analysis, modeling, precision intervention, and enabling technologies define the program's scope.
Closed
TA4 submissions
Enabling-technologies solution summaries closed October 21 at 3 p.m. ET; ARPA-H lists the track as shut to new submissions.
Dec 2, 2026
Next deadline
Analysis and modeling solution summaries are due; the submission window opens November 18.
Jan 19, 2027
Final proposal deadline
Precision intervention closes the solution-summary cycle; full proposals follow.

Voices

Curated perspectives — historical figures and your fellow readers.

Sign up to generate historical perspectives on this story.

Log in Sign Up

People Involved

Robert F. Kennedy Jr.
Robert F. Kennedy Jr.
Secretary of Health and Human Services
Announced SPECTRA as part of his autism policy agenda
RS
Russell Shilling
SPECTRA Program Manager, ARPA-H
Leads SPECTRA; the first submission window closed October 21 after he announced the three-day extension

Organizations Involved

Advanced Research Projects Agency for Health
Advanced Research Projects Agency for Health
Federal research agency
Administering SPECTRA; TA4 closed to new submissions on October 21, with three technical areas still to come

ARPA-H funds high-risk, high-reward biomedical research at an accelerated pace.
U.S. Department of Health and Human Services (HHS)
U.S. Department of Health and Human Services (HHS)
Federal Cabinet Department
Parent agency of ARPA-H

HHS oversees ARPA-H and the public health agencies including the CDC and FDA.

Timeline

September 2026 October 2026

6 events Latest: October 21st, 2026 · 2 weeks ago
Tap a bar to jump to that date

  1. TA4 solution summaries close

    Latest Procedural

    The deadline for enabling-technologies solution summaries passed at 3 p.m. ET. ARPA-H's program page now states that TA4 is closed to new submissions.

  2. ARPA-H extends TA4 deadline to October 21

    Procedural

    Amendment 1 to the SPECTRA solicitation moved TA4 solution summaries from October 18 to October 21 at 3 p.m. ET. Program manager Russell Shilling announced the extension publicly.

  3. TA4 submission portal opens

    Procedural

    ARPA-H opened the submission window for enabling technologies proposals at solutions.arpa-h.gov. Solution summaries were originally due October 18; ARPA-H later moved the deadline to October 21.

  4. Program details reach broader reporting

    Announcement

    Fierce Biotech reports on SPECTRA's end-to-end system for identifying ASD risk factors, matching patients to interventions, and accelerating clinical research.

  5. ARPA-H launches SPECTRA program

    Launch

    ARPA-H formally announces SPECTRA with four technical areas spanning biological analysis, AI modeling, precision intervention, and enabling technologies.

  6. Bloomberg reports HHS planning SPECTRA

    Report

    Bloomberg News reviews a draft document outlining the initiative, citing plans to fill gaps in "the missing biology needed to treat earlier."

Scenarios

1

SPECTRA awards contracts across all four technical areas

Likely Resolves by Q2 2027

Discussed by: ARPA-H procurement analysts and program officers

Proposals arrive by the October, December, and January deadlines. Full proposals follow, and ARPA-H announces awards in mid-2027. The program then begins building the federated AI platform, multi-omics analysis tools, and embedded assessment devices it outlined. This path validates the program's ambitious scope and sets up multi-year research timelines.

2

SPECTRA misses deadlines or consolidates scope

Possible Resolves by Feb 28, 2027

Discussed by: Government procurement analysts

The program spans genetics, exposome, microbiome, immune, and family factors, demand for cross-disciplinary teams that may not form quickly. Insufficient proposals in one or more technical areas could force ARPA-H to extend deadlines, split solicitations, or merge technical areas. The program would proceed but on a narrower footprint than designed.

3

Congress cuts or restructures SPECTRA funding

Uncertain Resolves by Mar 15, 2027

Discussed by: Congressional appropriations watchers

Autism research sits on politically sensitive terrain. Kennedy's vaccine-related history could draw scrutiny to the program's framing, and budget pressures in the FY2027 appropriations cycle could reduce its allocation. The program would either scale back its technical areas or continue with a reduced footprint, delaying the diagnostic tools it promises.

Historical Context

2 moments from history that rhyme with this story — and how they unfolded.

October 1990 – April 2003

Human Genome Project (1990–2003)

The U.S. government coordinated an international effort to map the complete human genome, a project of similar ambition to SPECTRA in scale and technical difficulty. Researchers from multiple institutions and countries shared data through centralized databases.

Then

The project delivered a complete human genome sequence in 2003, two years early and under budget.

Now

It established open-data norms in biomedical research and spawned the genomics industry, including direct-to-consumer genetic testing.

Why this matters now

SPECTRA follows the same template: a federally funded, multi-institution research program built on shared data infrastructure. The comparison suggests both the potential payoff and the coordination challenges.

May 2013

DSM-5 autism criteria revision (2013)

The American Psychiatric Association consolidated autism subtypes, including Asperger's syndrome and PDD-NOS, into a single autism spectrum disorder diagnosis. The change affected eligibility for services and reshaped the clinical research landscape.

Then

Some families lost specific diagnoses and services while others gained broader spectrum coverage.

Now

The single-spectrum framework became the standard for autism research and clinical care, shaping how clinicians and researchers talk about the condition.

Why this matters now

SPECTRA aims to go further by replacing categorical diagnosis with continuous, data-driven trajectories. If it succeeds, it would redefine how autism is assessed and matched to interventions.

Sources

(15)
+9
ARPA-H Bloomberg News Fierce Biotech Its News Times Observer News Group Kronos Digital FedOps ARPA-H (via Everglade) Disability Scoop FedSift LinkedIn (Russell Shilling) OPEN MINDS ARPA-H ARPA-H ARPA-H